Robert Daniel Slone

Robert Daniel Slone is an accomplished Process Development Scientist II at Precigen, where responsibilities include optimizing manufacturing processes for UltraCAR-T® cell therapy and supporting phase I clinical trials. Prior experience includes roles as a Scientist at Propagenix, where primary human tumor cells were isolated and characterized, and as a Research Associate II at Lonza, contributing to custom cell culture services. Slone has also held positions at DSM, Kinetic Concepts Inc, Princeton University, and Rutgers University, showcasing a strong background in cellular and developmental biology. Academic qualifications include a Master of Science in Cellular and Developmental Biology and a Bachelor of Arts in Molecular Biology and Biochemistry, both from Rutgers University.